Spineway

Pre-Annual General Meeting Information • Feb 19, 2024

Combined General Meeting of March 25, 2024 Availability of preparatory documents

Spineway informs its shareholders that they are invited to attend the Combined General Meeting to be held on Monday, March 25, 2024 at 16:00 p.m. at the Group's headquarters, 7 allée Moulin Berger in Ecully (69).

The notice of meeting, which is valid as a notice of convocation, including the agenda and the text of the resolutions presented to the General Meeting, was published in the Bulletin des Annonces Légales Obligatoires (BALO) of February 19, 2024. Details of how to participate and vote at this meeting are included in this notice.

The notice of meeting, as well as all the documents and information provided for in Article R.225-83 of the French Commercial Code, may be consulted on the company's website, under the heading "Investors/Regulated Information": https://spineway.com/investors/regulated-information/.

Next events: March 25, 2024 – Annual General Meeting April 16, 2024 – Q1 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES) Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.

Spineway has an international network of over 50 independent distributors and more than 70% of its revenue comes from exports. ISIN: FR001400BVK2 - ALSPW

Contacts :

Shareholder - services line Available Tuesday through Thursday +33 (0)806 70 60 60

Investor relations Solène Kennis spineway@aelium.fr